Company Profile

Adhaere Pharmaceuticals Inc
Profile last edited on: 2/18/19      CAGE: 6BN11      UEI: N4AMJWFFQJX5

Business Identifier: Small molecule therapeutics for the treatment of inflammatory and autoimmune diseases
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

11950 SW 72 Place
Pinecrest, FL 33156
Location: Single
Congr. District: 27
County: Miami-Dade

Public Profile

Though the detail is not readily available, it does seem that in October 2018, there was a merger/acquisition transaction involving San Diego based Gossamer Bio (fdba FSG, Bio, Inc) and Adhaere Pharmaceuticals, Inc. The latter has been identifed as a privately held company developing novel small molecule therapeutics for the treatment of inflammatory and autoimmune diseases. The company's approach organized around a unique way of targeting adhesion receptors on leukocytes. Adhaere has also created a broadly applicable proprietary technology platform for discovery of a pipeline of novel therapeutics. With one small trache of folllow-on funding on completion of Phase I in 2016, no additional SBIR allocation is reported as having been made.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 NIH $600,000
Project Title: Medicinal Chemistry Based Optimization of Lead Compounds Against Multiple Scleros

Key People / Management

  Vibha Gupta -- President & Co-Founder

  Antonio J Barbosa